{"id":471134,"date":"2021-04-05T16:33:04","date_gmt":"2021-04-05T20:33:04","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=471134"},"modified":"2021-04-05T16:33:04","modified_gmt":"2021-04-05T20:33:04","slug":"arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/","title":{"rendered":"Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW HAVEN, Conn., April  05, 2021  (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced two upcoming presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021, which will be held virtually from April 10-15, 2021 and May 17-21, 2021. These presentations will describe the discovery of Arvinas\u2019 two clinical-stage PROTAC degraders, ARV-110 and ARV-471, including the first disclosures of their structures.<\/p>\n<p>Details for the presentations are as follows:<\/p>\n<p>\n        <strong>Title:<\/strong> Discovery of ARV-110, a first in class androgen receptor degrading PROTAC\u00ae for the treatment of men with metastatic castration resistant prostate cancer<br \/><strong>Date and Time: <\/strong>April 11, 2021 from 2:05 PM &#8211; 2:15 PM ET<br \/><strong>Presenter: <\/strong>Lawrence B. Snyder, Ph.D., Executive Director of Medicinal Chemistry at\u00a0Arvinas<br \/><strong>Session Title: <\/strong>New Therapeutics Targeting Molecular Drivers in Cancer<\/p>\n<p>\n        <strong>Title:<\/strong> The discovery of ARV-471, an orally bioavailable estrogen receptor degrading PROTAC\u00ae for the treatment of patients with breast cancer<br \/><strong>Date and Time: <\/strong>April 11, 2021 from 2:20 PM &#8211; 2:30 PM ET<br \/><strong>Presenter: <\/strong>Lawrence B. Snyder, Ph.D., Executive Director of Medicinal Chemistry at\u00a0Arvinas <br \/><strong>Session Title: <\/strong>New Therapeutics Targeting Molecular Drivers in Cancer<\/p>\n<p>Abstracts will be available for registered attendees on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ffbPMbBPhZ9S9p-3lEbDnUUdo474YGISY6ppcfUXDVw4B1BmhffflzTwGuUFhYtXBuDntykfy46lY9xBFCCPX3uqldiXklAKl0ul563t-zlYYUADdMXEhYGysH9IYDHl\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">AACR website<\/a> beginning on April 9, 2021.<\/p>\n<p>\n        <strong>About\u00a0Arvinas<\/strong><br \/>\n        <br \/>Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC\u00ae Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC\u00ae targeted protein degraders, that are designed to harness the body\u2019s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC\u00ae protein degraders against validated and \u201cundruggable\u201d targets, the company has two clinical-stage programs: ARV-110 for the treatment of men with metastatic castrate-resistant prostate cancer; and ARV-471 for the treatment of patients with locally advanced or metastatic ER+\/HER2- breast cancer. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wG_JEsl6uSRSbNOaVO1856uEgH5DInS6UGOEPfZvyR7cS5TfVwgl9YAXbgdNU3nDky3OLWjx3pPNAWDpoS8-rg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.arvinas.com<\/a>.<\/p>\n<p>\n        <strong>Contacts for Arvinas<\/strong><\/p>\n<p>        <strong>Investors<\/strong><br \/>\n        <br \/>Will O\u2019Connor, Stern Investor Relations <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zLhVANZIkzfmqxKqkDIV4GrKcQXOkiB7De6-WgN1rsDIrq6yxTwNeR3Umfbx_yUc3zKApt_GaPETtDl6T1ZfFQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ir@arvinas.com<\/a><\/p>\n<p>\n        <strong>Media<\/strong><br \/>\n        <br \/>Kirsten Owens, Arvinas Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RaX9JqboxeQt7zR1wk3iSwLrLrQRe-gfqWbmbM0HSLAdyP9Ss8M5RDqQTEaZ6MntnR4ZpJ9fQ0BYpXXXFm8hShC5RlQ_p9xxqq7MK9m8DNk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">kirsten.owens@arvinas.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDk0OSM0MTA0MjY5IzIxMjIwNzY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/b60cb0f4-3e3d-45e3-aac4-f9e129e70b69\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW HAVEN, Conn., April 05, 2021 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced two upcoming presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021, which will be held virtually from April 10-15, 2021 and May 17-21, 2021. These presentations will describe the discovery of Arvinas\u2019 two clinical-stage PROTAC degraders, ARV-110 and ARV-471, including the first disclosures of their structures. Details for the presentations are as follows: Title: Discovery of ARV-110, a first in class androgen receptor degrading PROTAC\u00ae for the treatment of men with metastatic castration resistant prostate cancerDate and Time: April 11, 2021 from 2:05 PM &#8211; 2:15 PM &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-471134","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW HAVEN, Conn., April 05, 2021 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced two upcoming presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021, which will be held virtually from April 10-15, 2021 and May 17-21, 2021. These presentations will describe the discovery of Arvinas\u2019 two clinical-stage PROTAC degraders, ARV-110 and ARV-471, including the first disclosures of their structures. Details for the presentations are as follows: Title: Discovery of ARV-110, a first in class androgen receptor degrading PROTAC\u00ae for the treatment of men with metastatic castration resistant prostate cancerDate and Time: April 11, 2021 from 2:05 PM &#8211; 2:15 PM &hellip; Continue reading &quot;Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-05T20:33:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDk0OSM0MTA0MjY5IzIxMjIwNzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021\",\"datePublished\":\"2021-04-05T20:33:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\\\/\"},\"wordCount\":365,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMDk0OSM0MTA0MjY5IzIxMjIwNzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\\\/\",\"name\":\"Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMDk0OSM0MTA0MjY5IzIxMjIwNzY=\",\"datePublished\":\"2021-04-05T20:33:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMDk0OSM0MTA0MjY5IzIxMjIwNzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMDk0OSM0MTA0MjY5IzIxMjIwNzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/","og_locale":"en_US","og_type":"article","og_title":"Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 - Market Newsdesk","og_description":"NEW HAVEN, Conn., April 05, 2021 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced two upcoming presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021, which will be held virtually from April 10-15, 2021 and May 17-21, 2021. These presentations will describe the discovery of Arvinas\u2019 two clinical-stage PROTAC degraders, ARV-110 and ARV-471, including the first disclosures of their structures. Details for the presentations are as follows: Title: Discovery of ARV-110, a first in class androgen receptor degrading PROTAC\u00ae for the treatment of men with metastatic castration resistant prostate cancerDate and Time: April 11, 2021 from 2:05 PM &#8211; 2:15 PM &hellip; Continue reading \"Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-05T20:33:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDk0OSM0MTA0MjY5IzIxMjIwNzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021","datePublished":"2021-04-05T20:33:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/"},"wordCount":365,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDk0OSM0MTA0MjY5IzIxMjIwNzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/","name":"Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDk0OSM0MTA0MjY5IzIxMjIwNzY=","datePublished":"2021-04-05T20:33:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDk0OSM0MTA0MjY5IzIxMjIwNzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDk0OSM0MTA0MjY5IzIxMjIwNzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-announces-upcoming-presentations-at-the-american-association-for-cancer-research-annual-meeting-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/471134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=471134"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/471134\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=471134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=471134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=471134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}